ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008

Funding Opportunities Listed (12-page issue).

July 11, 2003

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More

July 3, 1987